pyrroles has been researched along with Experimental Hepatoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Gayyar, MMH; Alattar, A; Alshaman, R; El-Kannishy, SMH; Hamdan, AM; Hassan, HM | 1 |
| Cai, B; Huang, M; Jiang, J; Li, Z; Luo, M; Wang, L; Wu, L | 1 |
| Braeuning, A; Bucher, P; Buchmann, A; Hofmann, U; Schwarz, M | 1 |
| Bize, P; Decosterd, LA; Denys, A; Doelker, E; Dormond, O; Duran, R; Fuchs, K; Jordan, O; Namur, J | 1 |
| Baba, M; Hiramatsu, Y; Kamiya, K; Kawabata, T; Kikuchi, H; Kitagawa, M; Kondo, K; Konno, H; Ohta, M; Tanaka, T; Yamamoto, M | 1 |
| Chang, AP; Choo, SP; Chow, PK; Chung, AY; Huynh, H; Jin, Y; Koong, HN; Ngo, VC; Ong, HS; Ong, LC; Poon, D; Song, IC; Soo, KC; Thng, CH; Toh, HC; Zheng, L | 1 |
| Choi, SH; Chung, JW; Im, SA; Jae, HJ; Jun, S; Kim, HC; Park, JH; Yamasaki, Y | 1 |
| Chen, KF; Chen, PJ; Cheng, AL; Lin, JP; Liu, CY; Shiau, CW; Tai, WT; Yu, HC | 1 |
| MAN'KO, IV; PETROVA, MF; PUKHAL'SKAIA, ACh | 1 |
| Charnsangavej, C; Ellis, LM; Kan, Z; Kobayashi, S; Lee, TY; Phongkitkarun, S; Tang, Y | 1 |
| Ansiaux, R; Baudelet, C; Crokart, N; DeWever, J; Feron, O; Gallez, B; Grégoire, V; Jordan, BF; Martinive, P | 1 |
| Bucana, CD; Davis, DW; Drazan, KE; Ellis, LM; Liu, W; McConkey, DJ; McMahon, G; Ogura, Y; Reinmuth, N; Shaheen, RM; Tseng, WW; Vellagas, R; Wieczorek, AA | 1 |
12 other study(ies) available for pyrroles and Experimental Hepatoma
| Article | Year |
|---|---|
Therapeutic effects of blocking β-catenin against hepatocellular carcinoma-induced activation of inflammation, fibrosis and tumor invasion.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; beta Catenin; Cell Movement; Cytokines; Fibroblast Growth Factor 2; Fibrosis; Inflammation Mediators; Liver Neoplasms, Experimental; Male; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neovascularization, Pathologic; Pyridines; Pyrroles; Rats, Sprague-Dawley; Thiazolidinediones; Thioacetamide; Transforming Growth Factor beta1; Wnt Signaling Pathway | 2021 |
Design, synthesis, biological evaluation and structure-activity relationship of sophoridine derivatives bearing pyrrole or indole scaffold as potential antitumor agents.
Topics: Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Indoles; Liver Neoplasms, Experimental; Matrines; Mice; Molecular Docking Simulation; Molecular Structure; Pyrroles; Quinolizines; Structure-Activity Relationship | 2018 |
Chemically induced mouse liver tumors are resistant to treatment with atorvastatin.
Topics: Animals; Antineoplastic Agents; Atorvastatin; Biological Transport; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Genes, ras; Heptanoic Acids; Liver Neoplasms, Experimental; Liver-Specific Organic Anion Transporter 1; Male; Mice; Mutation; Organic Anion Transporters, Sodium-Independent; Organic Cation Transport Proteins; Proto-Oncogene Proteins B-raf; Pyrroles; Tumor Burden | 2014 |
Antitumoral Effect of Sunitinib-eluting Beads in the Rabbit VX2 Tumor Model.
Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Indoles; Liver Neoplasms, Experimental; Pyrroles; Rabbits; Sunitinib; Tumor Burden; Vascular Endothelial Growth Factor A | 2016 |
TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche.
Topics: Animals; Cell Movement; Chemokine CXCL1; Colonic Neoplasms; Gene Expression Profiling; Humans; Indoles; Interleukin-12 Subunit p40; Liver; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Neutrophils; Oligonucleotide Array Sequence Analysis; Oxindoles; Propionates; Pyrroles; Receptors, Interleukin-8B; RNA, Messenger; Xenograft Model Antitumor Assays | 2008 |
Sunitinib (SUTENT, SU11248) suppresses tumor growth and induces apoptosis in xenograft models of human hepatocellular carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Bevacizumab; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Hep G2 Cells; Humans; Indoles; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Mice, SCID; Neovascularization, Pathologic; Phosphorylation; Pyrroles; Sunitinib; Xenograft Model Antitumor Assays | 2009 |
Augmentation of chemotherapeutic infusion effect by TSU-68, an oral targeted antiangiogenic agent, in a rabbit VX2 liver tumor model.
Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Disease Models, Animal; Doxorubicin; Drug Therapy, Combination; Ethiodized Oil; Indoles; Infusions, Intravenous; Liver Neoplasms, Experimental; Neovascularization, Pathologic; Oxindoles; Propionates; Pyrroles; Rabbits; Statistics, Nonparametric; Tomography, X-Ray Computed | 2012 |
Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells.
Topics: Animals; Antineoplastic Agents; Biomimetic Materials; Carcinoma, Hepatocellular; Down-Regulation; HEK293 Cells; Humans; Liver Neoplasms, Experimental; Male; Mice; Mice, Nude; Oligopeptides; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Thiazoles; Treatment Outcome; Xenograft Model Antitumor Assays | 2012 |
[Studies on the effect of 6 alkaloids related to 1-methylpyrrolizidine on the growth of hepatoma and of certain other transplanted tumors in animals].
Topics: Alkaloids; Animals; Carcinoma, Hepatocellular; Liver Neoplasms; Liver Neoplasms, Experimental; Neoplasm Transplantation; Neoplasms, Experimental; Pyrroles | 1959 |
Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model.
Topics: Angiogenesis Inhibitors; Animals; Female; Indoles; Liver Neoplasms, Experimental; Microcirculation; Protein Kinase Inhibitors; Pyrroles; Random Allocation; Rats; Rats, Inbred F344; Tomography, X-Ray Computed | 2005 |
Mechanism of reoxygenation after antiangiogenic therapy using SU5416 and its importance for guiding combined antitumor therapy.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Hypoxia; Combined Modality Therapy; Cyclophosphamide; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fibrosarcoma; Indoles; Liver Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mitochondria; Oxygen; Oxygen Consumption; Pyrroles; Radiation-Sensitizing Agents | 2006 |
Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Division; Cell Survival; Colonic Neoplasms; Endothelium, Vascular; Indoles; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Oxindoles; Propionates; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Fibroblast Growth Factor; Receptors, Growth Factor; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor | 2001 |